News
21h
SurvivorNet on MSNAn Exciting Option For Difficult-To-Treat HER2+ Gastric Cancer: What New Data Means For PatientsFor the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...
Scientists at the University of Concepción in Chile have developed the world's first patented probiotic designed to prevent ...
AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to ...
Learn the crucial differences between IBS and colon cancer symptoms, risk factors, and treatments to protect your digestive ...
A clinical trial using engineered immune cells to hunt cancer cells has reported impressive results for solid tumours, a type ...
Bioengineering assistant professor Girgis Obaid at the University of Texas at Dallas and cancer researcher Rolf Brekken at UT ...
Doctors are seeing a particular uptick in breast cancer, lymphoma and colorectal cancer cases among younger adults.
A postdevelopment study showed patients with gastric cancer were generally satisfied with the design and functionality of an intelligent individualized nutrition management applet.
The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results